Effects of anthranil-, benzo-, and salicyl-hydroxamic acids on mouse brain amines and L-DOPA decarboxylase.
D000818:Animals; D001565:Benzoates; D001921:Brain / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D002395:Catecholamines / Q000032:analysis*; D004296:Dopa Decarboxylase / Q000378:metabolism*; D006877:Hydroxamic Acids / Q000494:pharmacology*; D066298:In Vitro Techniques; D051379:Mice; D012459:Salicylates; D062367:ortho-Aminobenzoates
D001565:Benzoates; D002395:Catecholamines; D006877:Hydroxamic Acids; D012459:Salicylates; D062367:ortho-Aminobenzoates; D004296:Dopa Decarboxylase